Lei Dong
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology
- Oncology
- Genetics top 10%
- Topics
- Autophagy in Disease and Therapy (7 papers)PI3K/AKT/mTOR signaling in cancer (6 papers)Protein Tyrosine Phosphatases (6 papers)
- Cited by
- Cancer ResearchGeneticsHematology
- Journals
- NatureOncogeneScientific Reports
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Lei Dong
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 702
- Cancer Research 376
- Immunology 183
- Oncology 167
- Genetics 144
Countries citing papers authored by Lei Dong
This map shows the geographic impact of Lei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Dong more than expected).
Fields of papers citing papers by Lei Dong
This network shows the impact of papers produced by Lei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Dong. The network helps show where Lei Dong may publish in the future.
Co-authorship network of co-authors of Lei Dong
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Dong. A scholar is included among the top collaborators of Lei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Dong. Lei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | 6 | |
| 8 | 17 | |
| 9 | 21 | |
| 10 | 30 | |
| 11 | 20 | |
| 12 | 116 | |
| 13 | 52 | |
| 14 | 107 | |
| 15 | 189 | |
| 16 | Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells. | 25 |
| 17 | 47 | |
| 18 | 5 | |
| 19 | 6 | |
| 20 | 3 |
About Lei Dong
Lei Dong is a scholar working on Cancer Research, Immunology and Physiology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Protein Tyrosine Phosphatases (6 papers). The work is most often cited by research in Cancer Research (376 citations), Genetics (144 citations) and Hematology (141 citations). Lei Dong has collaborated with scholars based in China, United States and France. Frequent co-authors include Xia Qin, Liqun Liu, Yu Zhu, Xiaobo Li, Shouwei Li, Feng Ren, Pei Zhang, Zhi‐Jun Qiu, Guang Li and Yuan Jiang. Their work appears in journals such as Nature, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.